Categories: News

NYSE Content Advisory: Pre-Market update + Fed Chair Jerome Powell Set to Deliver Jackson Hole Speech

NEW YORK, Aug. 22, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

- Advertisement -

Ashley Mastronardi delivers the pre-market update on August 22nd

- Advertisement -
  • Markets are closely watching the Fed’s economic policy symposium in Jackson Hole, where Chair Jerome Powell will speak at 10 a.m. ET.
  • Nearly 70% of traders expect a Fed rate cut in September amid dual concerns about inflation and employment highlighted in the Fed’s July meeting minutes.
  • The Fed’s July meeting minutes emphasized policymakers’ concerns about both inflation risks and employment, key elements of the Fed’s dual mandate.

Opening Bell
A Moment of Magic Foundation celebrates impacting 20,000 medically vulnerable children this year and to champion joy, connection, and emotional support as essential to every child’s healing journey.

- Advertisement -

Closing Bell
YPO, the global leadership community of chief executives in 150 countries, celebrates 75 years and the appointment of Debby Carreau as Global Chairman.

- Advertisement -

Click here to download the NYSE TV App

- Advertisement -

Video – https://mma.prnewswire.com/media/2756156/NYSE_Market_Update_Aug_22.mp4

- Advertisement -

Logo – https://mma.prnewswire.com/media/2581322/New_York_Stock_Exchange_Logo.jpg

- Advertisement -

 

- Advertisement -

 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/nyse-content-advisory-pre-market-update–fed-chair-jerome-powell-set-to-deliver-jackson-hole-speech-302536677.html

- Advertisement -

Recent Posts

Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (ADA) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study

•Translational data presented at ADA demonstrate icovamenib’s potential to promote muscle preservation and fat reduction,…

3 hours ago

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026

Presentations will feature clinical results for ribupatide, a GLP-1/GIP receptor dual agonist being developed as…

3 hours ago

Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress

Clinical benefit, including remissions, demonstrated in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA)…

3 hours ago

Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules

June 05, 2026 20:13 ET  | Source: Bluejay Diagnostics, Inc. $8.5 million upfront with up…

3 hours ago